ADRx, Inc.
- Biotech or pharma, therapeutic R&D
ADRx is a preclinical biotech company focused on halting diseases of aging. Our structure-based platform translates knowledge of pathological protein-protein interactions into long-sought inhibitors and disaggregators of tau, TDP-43 and alpha-synuclein.